cupure logo
google2025septembersamsungappleifapowerhintsiphonelights

Drug Makers And Payers To Blame For Biosimilar Barriers In U.S. Market

Drug Makers And Payers To Blame For Biosimilar Barriers In U.S. Market
The U.S. biosimilar market is riddled with barriers. Both drug makers and payers are to blame. Patients suffer with less access and higher cost-sharing than is warranted.

Comments

Similar News

Tech news